title: Gossypol overcomes stroma-mediated resistance to the BCL2 inhibitor ABT-737 in chronic lymphocytic leukemia cells ex vivo.
authors: 1] Department of Pharmacology and Toxicology, Giesel School of Medicine at Dartmouth, One Medical Center Drive, Lebanon, NH, USA [2] Norris Cotton Cancer Center, Giesel School of Medicine at Dartmouth, One Medical Center Drive, Lebanon, NH, USA.
authors: R
authors: R
authors: Soderquist
authors: D J P
authors: DJ
authors: Bates
authors: A V
authors: AV
authors: Danilov
authors: A
authors: A
authors: Eastman
mesh_terms: D001713:Biphenyl Compounds / Q000494:pharmacology*; D003272:Contraceptive Agents, Male / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D006072:Gossypol / Q000494:pharmacology*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D009596:Nitrophenols / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D017154:Stromal Cells / Q000187:drug effects* / Q000473:pathology; D013449:Sulfonamides / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: C501332:ABT-737; D001713:Biphenyl Compounds; D003272:Contraceptive Agents, Male; D009596:Nitrophenols; C498702:PMAIP1 protein, human; D010879:Piperazines; D019253:Proto-Oncogene Proteins c-bcl-2; D013449:Sulfonamides; D006072:Gossypol
references: Genes Dev. 2005 Jun 1;19(11):1263-8
references: 15937216
references: Cell Death Differ. 2011 May;18(5):864-73
references: 21113147
references: Clin Cancer Res. 2012 Jan 15;18(2):487-98
references: 22128299
references: Blood. 2011 Jan 6;117(1):156-64
references: 20971952
references: Clin Cancer Res. 2009 May 1;15(9):3172-6
references: 19366825
references: Blood. 2009 Apr 30;113(18):4403-13
references: 19008458
references: J Clin Oncol. 2012 Feb 10;30(5):488-96
references: 22184378
references: Blood. 1998 May 1;91(9):3379-89
references: 9558396
references: J Biol Chem. 2011 Jul 15;286(28):24882-95
references: 21628457
references: Nature. 2005 Jun 2;435(7042):677-81
references: 15902208
references: Immunol Invest. 1996 Jan-Mar;25(1-2):79-89
references: 8675236
references: Mol Cancer Ther. 2008 Jul;7(7):2192-202
references: 18645028
references: Nat Med. 2013 Feb;19(2):202-8
references: 23291630
references: Cancer Res. 2008 May 1;68(9):3421-8
references: 18451170
references: Blood. 2012 Jun 14;119(24):5807-16
references: 22538851